Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Operating Leases: 2023

Historic Operating Leases for Silence Therapeutics (SLN) over the last 1 years, with Dec 2023 value amounting to $118,000.

  • Silence Therapeutics' Operating Leases was N/A to $97,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $97,000, marking a year-over-year change of. This contributed to the annual value of $118,000 for FY2023, which is N/A change from last year.
  • Per Silence Therapeutics' latest filing, its Operating Leases stood at $118,000 for FY2023.
  • In the past 5 years, Silence Therapeutics' Operating Leases ranged from a high of $118,000 in FY2023 and a low of $118,000 during FY2023.
  • Over the past 1 years, Silence Therapeutics' median Operating Leases value was $118,000 (recorded in 2023), while the average stood at $118,000.